A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder
Michael E. Thase(Veterans Health Administration), Sanjay Dubé, Olawale Osuntokun, David Henley(Janssen (United States)), Susan B. Watson, S. Corya, Michael Case(Eli Lilly (United States)), T.M. Sanger
Cited by 230
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k